Home Online Features Lumicell Announces U.S. Launch and First Commercial Use of LumiSystem™, Pioneering Real-Time Detection of Residual Breast Cancer During Lumpectomy
Lumicell Announces U.S. Launch and First Commercial Use of LumiSystem™, Pioneering Real-Time Detection of Residual Breast Cancer During Lumpectomy
Hand-out
Press Releases
January 27, 2025

Lumicell Announces U.S. Launch and First Commercial Use of LumiSystem™, Pioneering Real-Time Detection of Residual Breast Cancer During Lumpectomy

By Lumicell, Inc.

LumiSystem is the first and only fluorescence-guided imaging technology for breast cancer detection, enabling a more complete resection

bradford

The Bradford Era

email
Local & Social